"Mobilized by the tireless Sharav the media reacted sharply. Sandoz [Pharmaceuticals] found itself denounced in front-page articles in the New York Times and Wall Street Journal" [p. 159]
"In Sharav's view, quite a few protocols were wrong, and some of the press were beginning to agree with her By November 1, 1994, she had run a workshop that laid out numerous consumer complaints for the first time before a broad public. Among the charges:
More than forty studies of systematic relapses, involving more than 2,381 patients, had passed muster by the erratically functioning Institutional Review Boards (IRBs) and were routinely published in medical journals. Several 'especially egregious experiments' had been reviewed and given grants by the National Institute of Mental Health"
[p 184]